|
Volumn 14, Issue 6, 2008, Pages 1920-
|
Does erythropoietin promote tumor growth?
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
HEAT SHOCK PROTEIN 70;
ANTINEOPLASTIC AGENT;
C 20;
ERYTHROPOIETIN ANTIBODY;
H 162;
MESSENGER RNA;
POLYCLONAL ANTIBODY;
RECOMBINANT ERYTHROPOIETIN;
UNCLASSIFIED DRUG;
CANCER SURVIVAL;
CELL PROLIFERATION;
CYTOPLASM;
DRUG SPECIFICITY;
GENE EXPRESSION;
GENE FUNCTION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LETTER;
LUNG NON SMALL CELL CANCER;
MOLECULAR WEIGHT;
PRIORITY JOURNAL;
TUMOR GROWTH;
ANTIBODY SPECIFICITY;
CANCER CHEMOTHERAPY;
CANCER THERAPY;
CYTOTOXICITY;
DRUG MECHANISM;
IMMUNOREACTIVITY;
MEDICAL INFORMATION;
MEDICAL RESEARCH;
PROGNOSIS;
PUBLIC HEALTH;
PUBLIC HEALTH SERVICE;
QUALITY OF LIFE;
CANCER INVASION;
CROSS REACTION;
DISEASE COURSE;
GENETICS;
IMMUNOLOGY;
LUNG TUMOR;
MORTALITY;
NOTE;
PATHOLOGY;
PHYSIOLOGY;
SURVIVAL;
ANTIBODY SPECIFICITY;
CARCINOMA, NON-SMALL-CELL LUNG;
CROSS REACTIONS;
DISEASE PROGRESSION;
ERYTHROPOIETIN;
ERYTHROPOIETIN, RECOMBINANT;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM INVASIVENESS;
PROGNOSIS;
SURVIVAL ANALYSIS;
|
EID: 41549101701
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: 10.1158/1078-0432.CCR-07-4612 Document Type: Letter |
Times cited : (3)
|
References (5)
|